The contractor shall provide the services of a consultant V to provide sharepoint designer/developer/architect support services for the OGD CS for all required bioequivalence review activities; for…
Ended Awarded Last action
- Contract number
- 75F40119F19088
- Awardee
-
Brillient Corporation UEI MMAVC7UGLJ78
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $460,737
Award facts
- Contract value 100% obligated
- $460,737.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541611 Administrative Management and General Management Consulting Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Labor Hours
- Place of performance
- Silver Spring, MD 20993, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$16,785 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $241,041 | |
| Original award | $236,482 |
About this award
The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a Blanket Purchase Agreement (BPA) call to Brillient Corporation, a Minority Owned Business and Subchapter S Corporation, to provide SharePoint Designer/Developer/Architect support services for all required bioequivalence review activities and workflow management under the Professional Services Schedule (PSS). The potential value of the contract is $460,737.28. Brillient, as a prime contractor, has delivered a variety of professional and technical services to federal agencies including HHS, FDA, and others. This award is not associated with a larger contract vehicle.
Description
The contractor shall provide the services of a consultant V to provide sharepoint designer/developer/architect support services for the OGD CS for all required bioequivalence review activities; for all issues relevant to the workflow management of OG
Quick answers
Who was awarded contract 75F40119F19088?
75F40119F19088 was awarded to Brillient Corporation by Food and Drug Administration (Department of Health and Human Services) on September 3, 2019.
How much is contract 75F40119F19088 worth?
The government has obligated $460,737 on 75F40119F19088.
Is contract 75F40119F19088 an order under another contract?
Yes. 75F40119F19088 is a BPA call under GS00F012BA-HHSF223201810005B, a blanket purchase agreement, on The Professional Services Schedule (PSS).
Was contract 75F40119F19088 competed?
The extent of competition for 75F40119F19088 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award